株式会社極東書店トップ > 商品一覧 > Developments in T Cell Based Cancer Immunotherapies. Softcover reprint of the original 1st ed. 2015
商品詳細
Developments in T Cell Based Cancer Immunotherapies. Softcover reprint of the original 1st ed. 2015
・ISBN 978-3-319-79330-6 paper EUR 149.99
¥40,091.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Ascierto, Paolo A. / Stroncek, David F. / Wang, Ena (eds.), |
|---|---|
| シリーズ | (Cancer Drug Discovery and Development) |
| 出版社 | (Springer International Publishing AG, SZ) |
| 出版年月 | 2019 |
| ページ数 | 305 pp. |
| 言語 | ENG |
| ニュース番号 | <A02-77353> |
解説
This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.